Kamada vs Rigel Pharmaceuticals
KMDA and RIGL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KMDA and RIGL compare
Kamada grew revenue faster over the last twelve months (13.2% versus 2.2% for Rigel Pharmaceuticals).
Rigel Pharmaceuticals scores higher on the StockData Score (11 against 5 for Kamada), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KMDA | RIGL |
|---|---|---|
| Size and price | ||
| Market cap | – | $831M |
| Share price | $8.09 | $44.46 |
| Change, 1 year | 11.1% | 11.3% |
| Change, 5 years | 44.5% | 45.8% |
| Beta (5Y) | 0.76 | 1.08 |
| Employees | 393 | 174 |
| StockData Score | ||
| Total score | 5 | 11 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 0 | 4 (better) |
| Health score | 3 | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 2.9× |
| P/S | – | 2.9× |
| P/B | – | 1.9× |
| EV/EBITDA | – | 9.2× |
| Growth | ||
| Revenue growth (TTM) | 13.2% (better) | 2.2% |
| Revenue growth, 5Y average | 6.3% | 22.1% (better) |
| Net income growth (TTM) | – | 171% |
| EPS growth (TTM) | – | 147% |
| EPS growth, 5Y average | −1.6% | – |
| Profitability | ||
| Gross margin | 40.8% | 89.6% (better) |
| Operating margin | 14.5% | 26.3% (better) |
| Net margin | – | 107% |
| Return on equity | – | 109% |
| Return on invested capital | – | 46.4% |
| Financial health | ||
| Net debt / EBITDA | −0.54 | – |
| Interest coverage | 26.8× (better) | 18.2× |
| Current ratio | 4.06 (better) | 2.39 |
| Altman Z-score | – | 4.98 |
| Piotroski F-score | – | 7 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 8.6% | 87.7% |
| Held by insiders | 45.3% | 3.3% |
| Insider net buying, 12 months | −$1.7M | −$306K (better) |
| Short interest, % of float | 0.53% | 14.0% |
Go deeper
- KMDA stock overview
- KMDA income statement
- KMDA valuation and score
- RIGL stock overview
- RIGL income statement
- RIGL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.